Search - tctmd.com

Displaying 21 - 40 of 318

Sort: Relevancy | Date

News Daily News

Ausencia de Datos: No Sabemos Cuál es la Mejor Estrategia para el Manejo de Pacientes con FA a Tratamiento con los Últimos Anticoagulantes y que Necesitan una PCI

August 17, 2016

News Daily News

冠脉内阿昔单抗显示对糖尿病 STEMI 患者有优势

August 11, 2016

Optimal Loading Dose and Delivery of P2Y12 Inhibitors: Should the Loading Dose Be Crushed?

Presentation ACC 2016

Optimal Loading Dose and Delivery of P2Y12 Inhibitors: Should the Loading Dose Be Crushed?

Presenter: Dominick Angiolillo

April 03, 2016

News Daily News

Crushed Prasugrel Pills Beat Whole Tablets for Controlling Platelets During Primary PCI

March 28, 2016

News Opinion Editor's Corner

ACC 2016: HOPE for Primary Prevention, TAVR in Moderate-Risk Patients, Deferred Stenting in STEMI, and More

March 28, 2016

News Daily News

急性心梗后随访延迟导致服药依从性降低

March 24, 2016

News Daily News

Medication Adherence Suffers With Delayed Follow-up After Acute MI

March 24, 2016

News Daily News

La Adherencia a la Medicación Sufre con Seguimientos Tardíos Post-IAM

March 24, 2016

News Daily News

计算器可估计采用内科治疗的 NSTE ACS 患者的自发心梗风险

March 16, 2016

News Daily News

Una Calculadora Estima el Riesgo de IM Espontáneo en Pacientes Víctimas de SCASEST Tratados Médicamente

March 16, 2016

News Daily News

Calculator Estimates Spontaneous MI Risk in Medically Managed NSTE ACS Patients

March 16, 2016

News Daily News

双倍剂量的氯吡格雷可以解决“吸烟者悖论”：GRAVITAS 分析

Michael O'Riordan

February 28, 2016

News Daily News

Análisis del Ensayo GRAVITAS: La ‘Paradoja del Fumador’ Desaparece con Dosis Dobles de Clopidogrel

Michael O'Riordan

February 28, 2016

News Daily News

‘Smoker’s Paradox’ Eliminated With Double Dose of Clopidogrel: GRAVITAS Analysis

Michael O'Riordan

February 28, 2016

Oral antiplatelet therapy in elderly New P2Y12 inhibitors are the right choice

Presentation JIM 2016

Oral antiplatelet therapy in elderly New P2Y12 inhibitors are the right choice

Presenter: Alberto Menozzi

February 11, 2016

Intravenous P2Y12 Receptor Inhibitors With Powerful Oral Antiplatelets Are The New Best Option!

Presentation JIM 2016

Intravenous P2Y12 Receptor Inhibitors With Powerful Oral Antiplatelets Are The New Best Option!

Presenter: Roxana Mehran

February 11, 2016

News Daily News

Ticagrelor Loading Dose Provides Faster Platelet Inhibition Than Clopidogrel in Ad Hoc PCI

February 09, 2016

News Opinion Conversations in Cardiology

Conversations in Cardiology: Post-PCI Clopidogrel in CHAMPION PHOENIX Trial of Cangrelor

February 08, 2016

News Daily News

急性心梗患者转院与治疗后护理中断及再入院更频繁相关

January 27, 2016

News Daily News

La Derivación Interhospitalaria de los IAM provoca Interrupciones en los Cuidados Posteriores y Más Rehospitalizaciones

January 27, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.